scispace - formally typeset
V

Valery T. Miller

Researcher at George Washington University

Publications -  19
Citations -  4098

Valery T. Miller is an academic researcher from George Washington University. The author has contributed to research in topics: Estrogen & Medroxyprogesterone acetate. The author has an hindex of 15, co-authored 19 publications receiving 4035 citations.

Papers
More filters
Journal ArticleDOI

Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

Valery T. Miller, +94 more
- 18 Jan 1995 - 
TL;DR: Estrogen alone or in combination with a progestin improves lipoproteins and lowers fibrinogen levels without detectable effects on postchallenge insulin or blood pressure and in women with a uterus, CEE with cyclic MP has the most favorable effect on HDL-C and no excess risk of endometrial hyperplasia.
Journal ArticleDOI

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.

TL;DR: Total serum triglyceride levels decreased in a dose-dependent manner, reductions in the 20-mg and 80-mg groups were statistically significant and atorvastatin did not cause a redistribution of triglycerides but consistently lowered triglycerides in all lipoprotein fractions.
Journal ArticleDOI

The Efficacy of Intensive Dietary Therapy Alone or Combined with Lovastatin in Outpatients with Hypercholesterolemia

TL;DR: The effects of the low-fat-low-cholesterol diet and lovastatin on lipoprotein levels were independent and additive, and the reduction in LDL cholesterol produced by the diet was small, and its benefit was possibly offset by the accompanying reduction in the level of HDL cholesterol.
Journal ArticleDOI

Effect of Postmenopausal Hormone Therapy on Lipoprotein(a) Concentration

TL;DR: Changes in Lp(a) associated with hormone therapy were positively correlated with changes in LDL cholesterol, total cholesterol, apolipoprotein B, and fibrinogen levels and were similar across subgroups defined by age, weight, ethnicity, and prior hormone use.